106 related articles for article (PubMed ID: 9352228)
1. Effect of cyclosporine A on the release of tissue factor pathway inhibitor from endothelial cells in heart transplant patients and cell culture.
Tiemann C; Prohaska W; Körfer R; Körner M; Brinkmann T; Kleesiek K
Eur J Clin Chem Clin Biochem; 1997 Sep; 35(9):661-7. PubMed ID: 9352228
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine and cremaphor modulate von Willebrand factor release from cultured human endothelial cells.
Collins P; Wilkie M; Razak K; Abbot S; Harley S; Bax C; Zaidi M; Blake D; Cunningham J; Newland A
Transplantation; 1993 Nov; 56(5):1218-23. PubMed ID: 8249125
[TBL] [Abstract][Full Text] [Related]
3. The direct effect of injectable cyclosporine and its vehicle, cremophor, on endothelial vascular cell adhesion molecule-1 expression. Ricinoleic acid inhibits coronary artery endothelial activation.
De Caterina R; Tanaka H; Nakagawa T; Hauptman PJ; Libby P
Transplantation; 1995 Aug; 60(3):270-5. PubMed ID: 7544037
[TBL] [Abstract][Full Text] [Related]
4. Increased release of von Willebrand factor antigen by endothelial cells whilst in active growth phase.
Blann AD
Cell Biol Int Rep; 1991 Jun; 15(6):493-8. PubMed ID: 1742796
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of cyclosporin and cremophor EL on endothelial function and vascular smooth muscle in the isolated rat heart.
Mankad P; Spatenka J; Slavik Z; O'Neil G; Chester A; Yacoub M
Cardiovasc Drugs Ther; 1992 Feb; 6(1):77-83. PubMed ID: 1576098
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell-derived high molecular weight von Willebrand factor is converted into the plasma multimer pattern by granulocyte proteases.
Tsai HM; Nagel RL; Hatcher VB; Sussman II
Biochem Biophys Res Commun; 1989 Feb; 158(3):980-5. PubMed ID: 2493251
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced von Willebrand factor release is blocked by verapamil.
Wilkie ME; Stevens CR; Cunningham J; Blake D
Miner Electrolyte Metab; 1992; 18(2-5):141-4. PubMed ID: 1465048
[TBL] [Abstract][Full Text] [Related]
8. The tethered ligand receptor is the responsible receptor for the thrombin induced release of von Willebrand factor from endothelial cells (HUVEC).
Storck J; Küsters B; Zimmermann ER
Thromb Res; 1995 Feb; 77(3):249-58. PubMed ID: 7740517
[TBL] [Abstract][Full Text] [Related]
9. The roles of protein kinase C and intracellular Ca2+ in the secretion of von Willebrand factor from human vascular endothelial cells.
Carew MA; Paleolog EM; Pearson JD
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):631-5. PubMed ID: 1530595
[TBL] [Abstract][Full Text] [Related]
10. Effect of TNF-alpha, Shiga toxin and calcium ionophore on Weibel-Palade body content of endothelial cells: possible implications for the hemolytic uremic syndrome.
Kaye SA; Obrig TG
Thromb Res; 1995 Aug; 79(4):415-21. PubMed ID: 7482445
[No Abstract] [Full Text] [Related]
11. Effects of cyclosporin A and dexamethasone on haemostatic and vasoactive functions of vascular endothelial cells.
Huang LQ; Whitworth JA; Chesterman CN
Blood Coagul Fibrinolysis; 1995 Jul; 6(5):438-45. PubMed ID: 8589211
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a storage and secretory organelle containing Von Willebrand protein from cultured human endothelial cells.
Reinders JH; De Groot PG; Gonsalves MD; Zandbergen J; Loesberg C; Van Mourik JA
Biochim Biophys Acta; 1984 Jul; 804(3):361-9. PubMed ID: 6430353
[TBL] [Abstract][Full Text] [Related]
13. Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells.
Sporn LA; Marder VJ; Wagner DD
J Cell Biol; 1989 Apr; 108(4):1283-9. PubMed ID: 2494192
[TBL] [Abstract][Full Text] [Related]
14. High-dose diltiazem prevents migration and proliferation of vascular smooth muscle cells in various in-vitro models of human coronary restenosis.
Voisard R; Koschnick S; Baur R; Vogel U; Mattfeldt T; Hemmer W; Hannekum A; Höher M; Hombach V
Coron Artery Dis; 1997; 8(3-4):189-201. PubMed ID: 9237030
[TBL] [Abstract][Full Text] [Related]
15. Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells.
van den Eijnden-Schrauwen Y; Atsma DE; Lupu F; de Vries RE; Kooistra T; Emeis JJ
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2177-87. PubMed ID: 9351387
[TBL] [Abstract][Full Text] [Related]
16. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
[TBL] [Abstract][Full Text] [Related]
17. Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells.
Vischer UM; Barth H; Wollheim CB
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):883-91. PubMed ID: 10712417
[TBL] [Abstract][Full Text] [Related]
18. Epinephrine induces von Willebrand factor release from cultured endothelial cells: involvement of cyclic AMP-dependent signalling in exocytosis.
Vischer UM; Wollheim CB
Thromb Haemost; 1997 Jun; 77(6):1182-8. PubMed ID: 9241755
[TBL] [Abstract][Full Text] [Related]
19. Effects of binding of ligand (FVIIa) to induced tissue factor in human endothelial cells.
Wiiger MT; Pringle S; Pettersen KS; Narahara N; Prydz H
Thromb Res; 2000 May; 98(4):311-21. PubMed ID: 10822078
[TBL] [Abstract][Full Text] [Related]
20. Perturbation of cultured human vascular endothelial cells by phorbol ester or thrombin alters the cellular von Willebrand factor distribution.
Reinders JH; Vervoorn RC; Verweij CL; van Mourik JA; de Groot PG
J Cell Physiol; 1987 Oct; 133(1):79-87. PubMed ID: 3499441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]